Canopy Growth (CGC) Sales of Property, Plant and Equipment (2021 - 2025)
Canopy Growth (CGC) Sales of Property, Plant and Equipment (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Sales of Property, Plant and Equipment (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 1.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 6.88 Mn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 8.20 Mn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Canopy Growth | 437.04 Mn | 190.03 Mn | 16.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,585.43 |
| Dec 31, 2025 | 3,585.43 |
| Jun 30, 2025 | 3,608.56 |
| Jun 30, 2025 | 3,608.56 |
| Sep 30, 2024 | 4,398.32 |
| Sep 30, 2024 | 4,398.32 |
| Jun 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | 3.60 Mn |
| Mar 31, 2024 | 221,891.85 |
| Mar 31, 2024 | 221,891.85 |
| Dec 31, 2023 | 981,339.46 |
| Dec 31, 2023 | 981,339.46 |
| Sep 30, 2023 | 51.67 Mn |
| Sep 30, 2023 | 51.67 Mn |
| Jun 30, 2023 | 61.90 Mn |
| Jun 30, 2023 | 61.90 Mn |
| Mar 31, 2023 | 2.01 Mn |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 81,037.32 |
| Dec 31, 2022 | 81,037.32 |